DDrare: Database of Drug Development for Rare Diseases

3h-cholesterol bound to albumin (DrugBank: Cholesterol)

2 diseases

ID	Disease name (Link within this page)	Number of trials
259	Lecithin-cholesterol acyltransferase deficiency	1
261	Tangier disease	1

259. Lecithin-cholesterol acyltransferase deficiency [ 1 clinical trial, 2 drugs, (DrugBank: 1 drug), 0 drug target gene, 0 drug target pathway]

Searched query = "Lecithin-cholesterol acyltransferase deficiency", "LCAT deficiency", "Fish-eye disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 1 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01782027 (ClinicalTrials.gov)	October 2012	30/1/2013	Mendelian Reverse Cholesterol Transport Study	A Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL Metabolism	Cholesterol, HDL;Lipid Metabolism, Inborn Errors;Tangier Disease;LCAT Deficiency;Cholesteryl Ester Transfer Protein (CETP) Deficiency	Drug: 3H-cholesterol bound to albumin	University of Pennsylvania	NULL	Suspended	18 Years	75 Years	All	30	N/A	United States

261. Tangier disease [ 1 clinical trial, 2 drugs, (DrugBank: 1 drug), 0 drug target gene, 0 drug target pathway]

Searched query = "Tangier disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 1 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01782027 (ClinicalTrials.gov)	October 2012	30/1/2013	Mendelian Reverse Cholesterol Transport Study	A Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL Metabolism	Cholesterol, HDL;Lipid Metabolism, Inborn Errors;Tangier Disease;LCAT Deficiency;Cholesteryl Ester Transfer Protein (CETP) Deficiency	Drug: 3H-cholesterol bound to albumin	University of Pennsylvania	NULL	Suspended	18 Years	75 Years	All	30	N/A	United States